EP Patent

EP1205559B1 — Method for detecting pathogenic microorganisms and antimicrobial agents, method for evaluating the drug effect of antimicrobial agents, and antimicrobial agents

Assigned to Kaken Pharmaceutical Co Ltd · Expires 2009-06-24 · 17y expired

What this patent protects

A novel method for evaluating an effect of an antimicrobial agent which comprises infecting a non-human animal or a biosample with the pathogenic microorganism, administering an antimicrobial agent comprising a compound having an antimicrobial effect or a composition thereof befo…

USPTO Abstract

A novel method for evaluating an effect of an antimicrobial agent which comprises infecting a non-human animal or a biosample with the pathogenic microorganism, administering an antimicrobial agent comprising a compound having an antimicrobial effect or a composition thereof before or after the infection, then removing the antimicrobial agent, and thereafter detecting the viable pathogenic microorganism in the infected site with the pathogenic microorganism.

Drugs covered by this patent

Patent Metadata

Patent number
EP1205559B1
Jurisdiction
EP
Classification
—
Expires
2009-06-24
Drug substance claim
No
Drug product claim
No
Assignee
Kaken Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.